CCI
NEOS

Columbus Circle Investors’s Neos Therapeutics, Inc NEOS Stock Holding History

Columbus Circle Investors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-172,877
Closed -$1.58M – 300
2017
Q3 		$1.58M Sell
172,877
-100,057
-37% -$760K 0.03% 245
2017
Q2 		$1.99M Buy
272,934
+166,414
+156% +$1.26M 0.03% 205
2017
Q1 		$767K Buy
106,520
+64,216
+152% +$398K 0.01% 256
2016
Q4 		$247K Buy
+42,304
New +$286K ﹤0.01% 253

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbus Circle Investors's NEOS Position: Q4 2017 in Review

Columbus Circle Investors sold out of Neos Therapeutics, Inc (NEOS) in Q4 2017, closing a stake of 172,877 shares — an estimated $1.58M sold.

Columbus Circle Investors first reported a position in NEOS in Q4 2016 and held it in 4 quarters. The position peaked at $1.99M in Q2 2017. 82 funds tracked by Wall St. Rank hold NEOS as of Q4 2017.

  • Columbus Circle Investors reported no remaining Neos Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 172,877 Neos Therapeutics, Inc shares in Q4 2017, an estimated $1.58M.
  • Columbus Circle Investors first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 4 quarters.
  • Columbus Circle Investors's Neos Therapeutics, Inc position peaked at $1.99M in Q2 2017.
  • 82 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.